Core Viewpoint - Horizon Technology Finance Corporation is under investigation for potential securities fraud and unlawful business practices following disappointing financial results [1][3]. Financial Performance - For the fourth quarter and full year ended December 31, 2024, Horizon reported total investment income of $23.5 million, which was below the consensus estimate of $26.1 million and represented a decline both year-over-year and from the previous quarter [3]. - The net asset value per share decreased to $8.43 from $9.06 in the previous quarter, attributed to "stressed investments" by the CEO [3]. Market Reaction - Following the announcement of the financial results, Horizon's stock price fell by $0.96 per share, or 9.95%, closing at $8.65 per share on March 5, 2025 [4].

MIAMI BEACH, Fla., April 17, 2025 /PRNewswire/ -- Starwood Property Trust (NYSE: STWD) today announced that the Company will release its first quarter 2025 financial results on Friday, May 9, 2025 before the opening of trading on the New York Stock Exchange. A conference call will be held on Friday, May 9, 2025 at 10:00 a.m. Eastern Time.During the conference call, the Company's officers will review first quarter performance, discuss recent events and conduct a question-and-answer period.WebcastThe conferen ...

Core Insights - The article emphasizes the importance of innovation and disruption in the financial sector, particularly focusing on high-tech and early growth companies [1] Group 1: Company Insights - The financial researcher highlights a beneficial long position in NMFC shares, indicating confidence in the company's future performance [2] - The article discusses the potential for growth buyouts and value stocks, suggesting that these areas may present significant investment opportunities [1] Group 2: Industry Trends - There is a strong focus on the pace of technological advancements and their impact on investment strategies within the industry [1] - The article suggests that current events and major news in the industry are crucial for identifying potential investment opportunities [1]

Core Viewpoint - Horizon Technology Finance Corporation is under investigation for potential violations of federal securities laws and unlawful business practices, following disappointing financial results that led to a significant drop in stock price [1][2][3]. Financial Performance - For the fourth quarter and full year ended December 31, 2024, Horizon reported total investment income of $23.5 million, which was below the consensus estimate of $26.1 million and represented a decline from both the previous quarter and year-over-year [2]. - The net asset value per share decreased to $8.43 from $9.06 in the previous quarter, attributed to "stressed investments" by the CEO [2]. Stock Market Reaction - Following the announcement of the financial results, Horizon's stock price fell by $0.96 per share, or 9.95%, closing at $8.65 per share on March 5, 2025 [3].

Logan Ridge Finance Corporation (NASDAQ:LRFC) Q4 2024 Earnings Conference Call March 14, 2025 11:30 AM ET Company Participants Ted Goldthorpe - Chief Executive Officer, President and Director Brandon Satoren - Chief Financial Officer Patrick Schafer - Chief Investment Officer Conference Call Participants Christopher Nolan - Ladenburg Thalmann Operator Good morning, and welcome to Logan Ridge Finance Corporation's fourth quarter and full year ended December 31, 2024, earnings conference call. An earnings pre ...

Group 1 - Tevogen Bio, a clinical-stage specialty immunotherapy biotech company, is leveraging AI to enhance precision medicine and operational efficiencies [2][3][5] - The company has reported positive safety data from its proof-of-concept clinical trial and owns key intellectual property assets, including three granted patents and multiple pending patents related to AI [5][6] - Tevogen Bio aims to make advanced therapies more accessible and affordable by combining proprietary datasets with generative AI models [3][5] Group 2 - The recent AI discussion panel featured industry leaders discussing the transformative impact of AI across finance, biotech, and legal sectors [2][4] - The event highlighted the importance of tailoring AI applications to address unique challenges within each industry [3][4] - Tevogen Bio's leadership emphasizes the need for disruptive business models to sustain medical innovation and ensure patient accessibility [5][6]